Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

Share Price is delayed by 15 minutes
Get Live Data
113.50    0.00 (0.00%)
Bid:
110.00
Ask:
117.00
Spread: 7.00 (6.364%)
Market Cap: £15.31m
ITX Live PriceLast checked at - London Stock Exchange

Intraday Itaconix Plc Share Chart

Board Changes

19 Apr 2022 07:00

RNS Number : 4997I
Itaconix PLC
19 April 2022
 

For release: 07.00, 19 April 2022

 

Itaconix plc

("Itaconix" or the "Company")

 

Board Changes

 

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products, announces that Dr. Bryan Dobson will retire as an independent Non-Executive Director, to be replaced by Charlean Gmunder, with immediate effect.

Ms. Gmunder is Chief Operating Officer of Blue Apron Holdings Inc. (NYSE: APRN), a leader in fresh home meal kits sold and delivered directly to consumers in North America. She brings to the Board over 20 years of executive experience in marketing and sales, manufacturing, operations, and general management. Ms. Gmunder served as President and CEO of L.A. Dreyfus, a subsidiary of Wm. Wrigley Jr. Company, from 2000 to 2006, and in executive operating roles with National Starch, Chiquita Brands, Maple Leaf Foods, United Airlines, and several other firms prior to joining Blue Apron in 2020. She earned her Bachelor of Science degree in chemical engineering and her Master of Business Administration degree from Rutgers University.

Dr. Dobson steps down after contributing to the progress of the Company as a Non-Executive Director since 2012, including previously 3 years as the Chair of the Board.

 

Dr. James Barber, Chair of the Board, commented:

"We are delighted that our search has resulted in Charlean's election to our Board as an independent Non-Executive Director. She brings a very broad background in marketing, operations, and executive management in both B2B and B2C contexts. We are looking forward to working with her as we continue to expand our sales across our existing product lines and bring new, sustainable products to market based on our plant-based ingredient platform.

I want to especially thank Bryan for his many years of dedicated service to the Company, and for the depth of experience, thoughtfulness, and good judgement he has brought to our Board. We are grateful for his many contributions to Itaconix over the years."

 

Regulatory disclosures

In accordance with Schedule 2(g) of the AIM Rules for Companies, Charlean Louise Gmunder (nee Baiz) (aged 58) holds or has held in the past 5 years the following directorships and partnerships:

Current

Jobs for America's Graduates New Jersey (not for profit organization, advisory board member)

 

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules for Companies.

 

Enquiries:

 

Itaconix

+1 (603) 775 4400

John R. Shaw/Laura Denner

Belvedere Communications

+44 (0) 20 3687 2756

John West/Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby/Abigail Kelly/Milesh Hindocha - Corporate Finance

Andrew Burdis/Sunila de Silva - ECM

 

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAXVLFFLZLZBBX
Date   Source Headline
11th May 20157:05 amRNSDirector Declaration
5th May 20157:01 amRNSDirector/PDMR Shareholding
13th Apr 20157:00 amRNSNotice of AGM
30th Mar 20157:00 amRNSPreliminary Results
24th Mar 20157:15 amRNSDirector Declaration
9th Jan 20157:00 amRNSBlocklisting Interim Review
5th Jan 201512:00 pmRNSTotal Voting Rights
11th Dec 20147:00 amRNSHolding(s) in Company
10th Nov 20147:00 amRNSPatent Infringement Settled and Discontinued
10th Oct 20144:22 pmRNSTotal Voting Rights
29th Sep 20147:00 amRNSInterim Results
25th Sep 20147:00 amRNSGlobal licence signed with Solvay
26th Aug 20147:00 amRNSNew CEO start date confirmed
9th Jul 20147:00 amRNSBlocklisting Interim Review
4th Jul 20147:00 amRNSAppointment of Chief Executive Officer
2nd Jul 20147:00 amRNSTotal Voting Rights
23rd Jun 20147:01 amRNSNotification of Major Interest in Shares
23rd Jun 20147:00 amRNSNotification of Major Interest in Shares
9th Jun 20147:00 amRNSUS supply agreement for nicotine chewing gum
3rd Jun 20147:00 amRNSTotal Voting Rights
22nd May 201412:34 pmRNSResult of AGM
30th Apr 20143:16 pmRNSNotification of Major Interest in Shares
24th Apr 20147:00 amRNSAward under Long Term Incentive Plan
23rd Apr 201412:45 pmRNSNotification of Major Interest in Shares
23rd Apr 20147:00 amRNSNotice of AGM
22nd Apr 201411:58 amRNSTotal Voting Rights
14th Apr 20147:00 amRNSAward of Technology Strategy Board funding
31st Mar 20147:00 amRNSPreliminary Results
3rd Mar 20147:00 amRNSTotal Voting Rights
30th Jan 201411:39 amRNSBlock Listing
27th Jan 20147:00 amRNSDirectorate Change
24th Jan 20144:46 pmRNSHolding(s) in Company
10th Jan 20147:00 amRNSBlock Listing Six Monthly Return
20th Nov 20137:00 amRNSMarketing approval of nicotine gum in Europe
17th Oct 20137:00 amRNSSupply and Distribution Agreement with Amma Polska
11th Oct 20137:00 amRNSDirector/PDMR Shareholding and Total Voting Rights
25th Sep 20137:00 amRNSInterim Results
1st Aug 20137:00 amRNSTotal Voting Rights
22nd Jul 20137:00 amRNSAward of contract to supply nicotine gum
15th Jul 201312:20 pmRNSChange of Registered Office
9th Jul 20137:00 amRNSBlocklisting Interim Review
28th May 20132:02 pmRNSResult of AGM
17th Apr 20134:47 pmRNSHolding(s) in Company
17th Apr 20137:00 amRNSDirector's Dealings
9th Apr 20137:00 amRNSPositive test results for encapsulation technology
22nd Mar 20137:00 amRNSNotice of AGM and Posting of Annual Report
13th Mar 20137:00 amRNSPreliminary Results
1st Mar 20137:00 amRNSTotal Voting Rights
1st Feb 20132:42 pmRNSNotice of patent infringement proceedings
10th Jan 20137:01 amRNSAwards under Long Term Incentive Plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.